US Patent 9889142 Prostamide-containing intraocular implant
Patent 9889142 was granted and assigned to Allergan, Inc. on February, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 12 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Article (+339 characters)
Article
Patent abstract
Prostamide-containing biodegradable intraocular implants, prostamide compounds, prostamide-containing pharmaceutical compositions, and methods for making and using such implants and compositions for the immediate and sustained reduction of intraocular pressure and treatment of glaucoma in an eye of a patient are described.
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09889142 Prostamide-containing intraocular implant US Patent 9889142 Prostamide-containing intraocular implant
Infobox
Patent Number
0988914200
Patent Number
988914200
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
098891420
Date of Patent
February 13, 2018
0Patent Application Number
150759220
Date Filed
March 21, 2016
0Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
098891420
Date of Patent
February 13, 2018
0Patent Application Number
150759220
Date Filed
March 21, 2016
0Patent Primary Examiner
Edits on 18 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09889142 Prostamide-containing intraocular implant
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09889142
Date of patent
February 13, 2018
Patent application number
15075922
Date Filed
March 21, 2016
Patent primary examiner
Find more entities like US Patent 9889142 Prostamide-containing intraocular implant
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.